SEC Form 4 · accession 0001209191-17-037462
Myovant Sciences Ltd. · MYOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lynn Seely
Officer — Principal Executive Officer · Director
Period of report
May 31, 2017
Accepted (ET)
Jun 2, 2017 · 6:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001679082
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | May 31, 2017 | A | 564,111 | $0.00 | A | 1,692,333 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F11/3 of the shares will vest if the Issuer's stock price exceeds $30.00 per share for a continuous 5-day volume-weighted average price ("VWAP") period, an additional 1/3 of the shares will vest if the Issuer's stock price exceeds $60.00 per share for a continuous 5-day VWAP period, and the final 1/3 of the shares will vest if the Issuer's stock price exceeds $90.00 per share for a continuous 5-day VWAP period, provided the Reporting Person has provided continuous service to Myovant Sciences, Inc. or its affiliates on the date of each vesting milestone.